AlloSource | Not all processing facilities are created equal

First and foremost, only consider a facility accredited by the American Association of Tissue Banks (AATB) that uses Clinical Laboratories Improvement Act (CLIA) certified testing and environmental laboratories. The facility also must be in full compliance with the FDA current Good Tissue Practices (cGTP). Upon arrival at the facility, donor tissue should be entered into a reliable inventory system and subjected to a robust process for reducing bioburden. This process should be carried out in certified clean rooms. The process by which the tissue’s bioburden is measured and diminished should include:

Elimination or reduction of blood, debris and lipids
Use of validated bactericidal washes and/or treatments
Surface swab tests, solution extraction or destructive tests of companion tissue